Multiple Sclerosis Trial, Recruiting (NCT05633875)

Multiple Sclerosis Trial, Recruiting NCT05633875 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT05633875 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have Multiple Sclerosis and have already been taking part in one of these specific studies for 8 years or more: INFLASEP, FLUMATEP 1-2, or SHADOWTEP
You are an adult (18 years old or over)
You are covered by French social security or an equivalent scheme (not including "Aide Médicale d'Etat")
You have given your consent to take part in the trial

Who may not be able to join:

You are unable to have an MRI scan for any reason, including fear of enclosed spaces (claustrophobia), having a pacemaker, or having a foreign object in your eye
You are pregnant, breastfeeding, or not using an effective form of contraception
You currently have serious or poorly controlled problems with your kidneys, liver, blood, digestive system, lungs, heart, or any other ongoing neurological condition
You do not wish to be told if something unusual or medically significant is found on your MRI scan
You are currently taking part in another clinical trial that involves a treatment or intervention, unless your doctor agrees (confirm with trial site)
You are under any form of legal guardianship or protection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bruno Stankoff, Pr, Assistance Publique - Hôpitaux de Paris

Phone: 1 42 16 24 32

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05633875

Sponsor: Assistance Publique - Hôpitaux de Paris

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 1 42 16 24 32

More information: https://clinicaltrials.gov/study/NCT05633875

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have Multiple Sclerosis and have already been taking part in one of these specific studies for 8 years or more: INFLASEP, FLUMATEP 1-2, or SHADOWTEP
You are an adult (18 years old or over)
You are covered by French social security or an equivalent scheme (not including "Aide Médicale d'Etat")
You have given your consent to take part in the trial

Who may not be able to join:

You are unable to have an MRI scan for any reason, including fear of enclosed spaces (claustrophobia), having a pacemaker, or having a foreign object in your eye
You are pregnant, breastfeeding, or not using an effective form of contraception
You currently have serious or poorly controlled problems with your kidneys, liver, blood, digestive system, lungs, heart, or any other ongoing neurological condition
You do not wish to be told if something unusual or medically significant is found on your MRI scan
You are currently taking part in another clinical trial that involves a treatment or intervention, unless your doctor agrees (confirm with trial site)
You are under any form of legal guardianship or protection

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Assistance Publique - Hôpitaux de Paris

Registry

ClinicalTrials.gov

Start date

25 April 2023

Est. completion

25 June 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

EDSS (Expanded Disability Status Scale) score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov